A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy

Project: Research project

Description

A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy
StatusActive
Effective start/end date9/11/189/30/23

Funding

  • KADMON CORPORATION, LLC

Fingerprint

Graft vs Host Disease
Multicenter Studies
Safety
Therapeutics